University Hospitals

University Hospitals Health System is an independent non-profit healthcare organization based in Cleveland, Ohio, established in 1866. It provides a comprehensive range of medical services, including primary and specialty care, nursing, elder healthcare, rehabilitation, and home care services. University Hospitals Home Care Services Inc., a division of the system, offers both medical and non-medical services to patients in their homes, such as skilled nursing, physical therapy, social work, nutritional counseling, and personal care. The organization is committed to meeting the healthcare needs of northeast Ohio through strategic geographic expansion and diversification of services. Its leadership team oversees the management of the health system's assets, ensuring the delivery of quality care to the community.

Eric Beck

President and COO

5 past transactions

Axuall

Series B in 2023
Axuall provides a digital platform for verifying identities, credentials, and authenticity across various sectors. It specializes in healthcare workforce intelligence, enabling healthcare systems, staffing firms, and telehealth providers to streamline onboarding processes and gain valuable data insights for network planning and analytics.

STAQ Pharma

Series C in 2022
STAQ Pharma, Inc. is a Denver-based company that specializes in the manufacture and sale of compounded pharmaceutical medications. Initially known as QualMed Pharmacy, Inc., the company rebranded in 2018 and operates a cGMP-compliant outsourcing facility. STAQ Pharma produces a wide range of compounded medications, including non-sterile and sterile solutions, as well as repackaged sterile medications in prefilled syringes for hospital procedures. The company emphasizes safety, quality, and transparency in its operations, utilizing inventory systems to forecast demand and ensure timely availability of critical products for healthcare facilities. STAQ Pharma aims to enhance access to high-quality compounded medications through its online store and in-house production capabilities.

Babyscripts

Series B in 2021
Babyscripts is a developer of a virtual maternity care platform aimed at enhancing prenatal and postpartum care for pregnant mothers. The company's three-tiered approach allows healthcare providers to deliver tailored, risk-specific care anytime and anywhere. The first tier features a mobile app that offers daily educational content and resources throughout pregnancy and the postpartum period. The second tier incorporates remote monitoring through medical devices, enabling patients to track health metrics like blood pressure and alerting providers to potential risks. This system facilitates the transition of care beyond traditional clinical settings, enabling providers to focus on higher-risk patients while automating routine care. The third tier fosters collaboration between care teams and insurers, addressing challenges in care coordination and access, ultimately improving health outcomes and reducing costs. Through its innovative platform, Babyscripts aims to eliminate maternal mortality and enhance access to quality care for all mothers.

BioMotiv

Venture Round in 2013
BioMotiv is a therapeutic accelerator that develops a portfolio of novel medicines. As the mission-aligned development arm of The Harrington Project for Discovery and Development, it works with University Hospitals to advance breakthrough drugs from discovery to market. The Harrington Project is a large initiative backed by a $250 million commitment to accelerate therapeutic innovation. By coordinating upstream discovery with downstream development, BioMotiv seeks to shorten the pathway to new treatments for patients worldwide. The company was founded in 2012 and is based in the Cleveland area, Ohio.

BioMotiv

Venture Round in 2012
BioMotiv is a therapeutic accelerator that develops a portfolio of novel medicines. As the mission-aligned development arm of The Harrington Project for Discovery and Development, it works with University Hospitals to advance breakthrough drugs from discovery to market. The Harrington Project is a large initiative backed by a $250 million commitment to accelerate therapeutic innovation. By coordinating upstream discovery with downstream development, BioMotiv seeks to shorten the pathway to new treatments for patients worldwide. The company was founded in 2012 and is based in the Cleveland area, Ohio.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.